SCHEMBL156303

SCHEMBL156303

C=CN1C(=O)COCC1=O

nearest known ligand 0.31

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.31
GAA P10253 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3407533 0.76 BRD4 (0.40) POLB
SCHEMBL6366630 0.75
SCHEMBL213996 0.75
SCHEMBL11313584 0.75
SCHEMBL8614304 0.72
SCHEMBL6781952 0.70 BRD4 (0.40)
SCHEMBL631134 0.70
SCHEMBL4553513 0.69 CYP3A4 (0.41) POLBGAASMN1; SMN2
SCHEMBL157841 0.67
SCHEMBL11398111 0.66 POLB (0.30) POLBGAASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 775 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10551345-B2 Poly and copoly(N-vinylamide)s and their use in capillary electrophoresis APPLIED BIOSYSTEMS, LLC (US) 2020-02-04 US claimed
US-20170356877-A1 POLY AND COPOLY(N-VINYLAMIDE)S AND THEIR USE IN CAPILLARY ELECTROPHORESIS APPLIED BIOSYSTEMS, LLC (US) 2017-12-14 US claimed
US-20100051461-A1 Poly and Copolyn(N-Vinylamide)s and their use in Capillary Electrophoresis Life Technologies Corporation (US) 2010-03-04 US claimed
EP-2053067-A1 Poly and copoly (N-vinylamide)s and their use in capillary electrophoresis Applied Biosystems Inc. (US) 2009-04-29 EP claimed
EP-1636279-B1 POLY AND COPOLY (N -VINYLAMIDE)S AND THEIR USE IN CAPILLARY ELECTROPHORESIS APPLIED BIOSYSTEMS (US) 2009-02-18 EP claimed
EP-1636279-A1 POLY AND COPOLY (N -VINYLAMIDE)S AND THEIR USE IN CAPILLARY ELECTROPHORESIS Applera Corporation (US) 2006-03-22 EP claimed
US-20050025741-A1 Copolymers with (meth)acrylamides; improved separation of polynucleotides APPLIED BIOSYSTEMS, LLC 2005-02-03 US claimed
WO-2004104054-A1 POLY AND COPOLY (N-VINYLAMIDE)S AND THEIR USE IN CAPILLARY ELECTROPHORESIS APPLERA CORPORATION (US) 2004-12-02 WO claimed
EP-4748406-A1 MEDICAL ADHESIVE AGENT AND MEDICAL ADHESIVE SHEET Nitto Denko Corporation (JP) 2026-05-27 EP disclosed
US-12637595-B2 Pressure-sensitive adhesive sheet, optical member, and touch panel NITTO DENKO CORPORATION (JP) 2026-05-26 US disclosed
WO-2026100155-A1 ETCHING LIQUID, REPLENISHING LIQUID, AND COPPER WIRING FORMING METHOD メック株式会社 2026-05-15 WO disclosed
CN-122011949-A Optical adhesive sheet with release liner 日东电工株式会社 2026-05-12 CN disclosed
US-12624172-B2 Method for producing wetting agent for semiconductor, containing polyvinyl alcohol composition, polishing composition containing wetting agent for semiconductor, obtained by the production method, and method for producing polishing composition FUJIMI INCORPORATED (JP) 2026-05-12 US disclosed
US-20260125581-A1 METHOD FOR PRODUCING POLISHING COMPOSITION CONTAINING MODIFIED POLYVINYL ALCOHOL COMPOSITION AND POLISHING COMPOSITION CONTAINING MODIFIED POLYVINYL ALCOHOL COMPOSITION FUJIMI INCORPORATED (JP) 2026-05-07 US disclosed
US-20050025741-A1 Copolymers with (meth)acrylamides; improved separation of polynucleotides APPLIED BIOSYSTEMS, LLC 2005-02-03 US disclosed
WO-2004104054-A1 POLY AND COPOLY (N-VINYLAMIDE)S AND THEIR USE IN CAPILLARY ELECTROPHORESIS APPLERA CORPORATION (US) 2004-12-02 WO disclosed
US-6232475-B1 REACTING A SUBSTITUTED BROMOBENZENE WITH N-VINYLIMIDE; CATALYTIC HYDROGENATION BAYER AKTIENGESELLSCHAFT (DE) 2001-05-15 US disclosed
EP-0091039-B1 ANTI-FOULING AGENT Nitto Kasei Co., Ltd. (JP) 1986-10-01 EP disclosed
US-4526932-A Copolymer containing N-coordinated triorganotin compound NITTO KASEI CO., LTD. (JP) 1985-07-02 US disclosed
EP-0091039-A2 Anti-fouling agent Nitto Kasei Co., Ltd. (JP) 1983-10-12 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12624172-B2 Method for producing wetting agent for semiconductor, containing polyvinyl alcohol composition, polishing composition containing wetting agent for semiconductor, obtained by the production method, and method for producing polishing composition VCL, SMARCA1, SMARCD1 POLB 248/4885GAA 3875/4885SMN1; SMN2 1134/4885
US-20260125581-A1 METHOD FOR PRODUCING POLISHING COMPOSITION CONTAINING MODIFIED POLYVINYL ALCOHOL COMPOSITION AND POLISHING COMPOSITION CONTAINING MODIFIED POLYVINYL ALCOHOL COMPOSITION RIF1, REV1, POLR1A POLB 123/4885GAA 1511/4885SMN1; SMN2 1110/4885
US-12637595-B2 Pressure-sensitive adhesive sheet, optical member, and touch panel LCP1, CDH1, HSPA4L POLB 4111/4885GAA 4516/4885SMN1; SMN2 922/4885
US-20050025741-A1 Copolymers with (meth)acrylamides; improved separation of polynucleotides POLI, PCNA, POLL POLB 16/4885GAA 2599/4885SMN1; SMN2 963/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.